Jabbour, Elias
Paul, Shilpa
Kantarjian, Hagop
Article History
Accepted: 8 February 2021
First Online: 23 March 2021
Competing interests
: E.J. has acted as a consultant for and received research funding from Abbvie, Amgen, Bristol-Myers Squibb, Pfizer and Takeda. H.K. has acted as a consultant for and received research funding from Abbvie, Amgen, Bristol-Myers Squibb, Pfizer and Takeda. S.P. declares no competing interests.